Multi-modal Imputation for Alzheimer's Disease Classification

Deep learning has been successful in predicting neurodegenerative disorders, such as Alzheimer's disease, from magnetic resonance imaging (MRI). Combining multiple imaging modalities, such as T1-weighted (T1) and diffusion-weighted imaging (DWI) scans, can increase diagnostic performance. However, complete multimodal datasets are not always available. We use a conditional denoising diffusion probabilistic model to impute missing DWI scans from T1 scans. We perform extensive experiments to evaluate whether such imputation improves the accuracy of uni-modal and bi-modal deep learning models for 3-way Alzheimer's disease classification-cognitively normal, mild cognitive impairment, and Alzheimer's disease. We observe improvements in several metrics, particularly those sensitive to minority classes, for several imputation configurations.

Diffusion Bridge Models for 3D Medical Image Translation

Diffusion tensor imaging (DTI) provides crucial insights into the microstructure of the human brain, but it can be time-consuming to acquire compared to more readily available T1-weighted (T1w) magnetic resonance imaging (MRI). To address this challenge, we propose a diffusion bridge model for 3D brain image translation between T1w MRI and DTI modalities. Our model learns to generate high-quality DTI fractional anisotropy (FA) images from T1w images and vice versa, enabling cross-modality data augmentation and reducing the need for extensive DTI acquisition. We evaluate our approach using perceptual similarity, pixel-level agreement, and distributional consistency metrics, demonstrating strong performance in capturing anatomical structures and preserving information on white matter integrity. The practical utility of the synthetic data is validated through sex classification and Alzheimer's disease classification tasks, where the generated images achieve comparable performance to real data. Our diffusion bridge model offers a promising solution for improving neuroimaging datasets and supporting clinical decision-making, with the potential to significantly impact neuroimaging research and clinical practice.